1-Oxa-4,10-diazacyclotridecane-13-carboxylic acid,4-methyl-9-[(methylamino)carbonyl]-12-(2-methylpropyl)-3,11-dioxo-,(9S,12R,13S)- (359821-31-1)

Identification
Name:	1-Oxa-4,10-diazacyclotridecane-13-carboxylic acid,4-methyl-9-[(methylamino)carbonyl]-12-(2-methylpropyl)-3,11-dioxo-,(9S,12R,13S)-
CAS:	359821-31-1
Molecular Formula:	C₁₈H₃₁N₃O₆
Molecular Structure:
Properties
Safety Data

Other Product

2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-10-((4-hydroxyphenyl)methyl)-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, (7S-(7R*,10S*,12R*,13R*))-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-10-[(3-methoxyphenyl)methyl]-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, [7S-(7R*,10S*,12R*,13R*)]-
2-Oxa-4,6,8-triazadecan-10-oic acid,1-(9H-fluoren-9-yl)-9-[(4-hydroxyphenyl)methyl]-5-[(1S)-1-methylpropyl]-3,7-dioxo-, (5S,9S)-
3-Oxa-5,9,11-triazatridecan-13-oic acid,7-hydroxy-2,2,9-trimethyl-12-(2-methylpropyl)-4,10-dioxo-6-(phenylmethyl)-, methyl ester, (6R,7R,12R)-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-10-[(2-methoxyphenyl)methyl]-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, [7S-(7R*,10S*,12R*,13R*)]-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-10-((3,4,5-trimethoxyphenyl)methyl)-, 1,1-dimethylethyl ester, (7S-(7R*,10S*,12R*,13R*))-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 10-[(3,4-dimethoxyphenyl)methyl]-12-hydroxy-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, [7S-(7R*,10S*,12R*,13R*)]-
(1R,7S,8S,9S)-7-acetoxy-9-ethynyl-9-methyl-11-oxo-10-oxa-tricyclo[6.3.2.01,7]tridec-3-ene-4-carboxylic acid methyl ester
3,5,8,11-Tetraazatetradecanoicacid,13-amino-9-[[[(Z)-[(4R,5R)-5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)dihydro-4-hydroxy-2(3H)-furanylidene]methyl]amino]carbonyl]-14-(3-hydroxyphenyl)-6,10,11-trimethyl-4,7,12-trioxo-2-(phenylmethyl)-,(2S,6S,9S,10S,13S)-
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
12-Oxa-2,6,10-triazatetradecanoicacid,3-[[4-[2-[[(dimethylamino)carbonyl]oxy]ethoxy]phenyl]methyl]-4,8-dihydroxy-13,13-dimethyl-11-oxo-9-(phenylmethyl)-,1,1-dimethylethyl ester, (3S,4R,8R,9S)-
Hexanoic acid,3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-5-methyl-,(3aS,4R,7R,8aS,9S,10aR,12aS,12bR,13S,13aS)-7,12a-bis(acetyloxy)-13-(benzoyloxy)-3a,4,7,8,8a,9,10,10a,12,12a,12b,13-dodecahydro-9-hydroxy-5,8a,14,14-tetramethyl-2,8-dioxo-6,13a-methano-13aH-oxeto[2'',3'':5',6']benzo[1',2':4,5]cyclodeca[1,2-d]-1,3-dioxol-4-ylester, (2R,3S)-
Benzoic acid,4-[[[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]methylamino]carbonyl]-,monosodium salt (9CI)
1/C13H9IO2/c15-13-11-8-4-5-9-12(11)14(16-13)10-6-2-1-3-7-10/h1-9
2-Oxa-4,6,8-triazadecan-10-oic acid,1-(9H-fluoren-9-yl)-9-(2-methylpropyl)-3,7-dioxo-5-(phenylmethyl)-,methyl ester, (5S,9S)-
2-[(8'R,9'S,10'S,13'S,14'S)-13'-methyl-1',2',4',7',8',9',11',12',13',14',15',16'-dodecahydro-10'H-dispiro[1,3-dioxolane-2,17'-cyclopenta[a]phenanthrene-3',2''-[1,3]dioxolan]-10'-yl]ethanamine acetate (1:1)
Carbamic acid,(2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1,3-dioxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl)methyl-,ethyl ester, (9S,10S,11S,12R)- (9CI)
11-methyl-9-(2-oxo-2H-1-benzopyran-3-yl)-8-oxa-10-azatricyclo[7.3.1.02,7]trideca-2,4,6,11-tetraene-12-carboxylic acid
1/C13H10O/c14-13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)13/h1-8,13-14
1/C11H10O2/c1-9(12)3-4-10-5-7-11(13-2)8-6-10/h5-8H,1-2H